Fabrizio Caldera

Dr. Fabrizio Caldera

Dipartimento di Chimica, Università degli Studi di Torino, Via P. Giuria, 7-10125 Torino, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Materials
Verified
Journal Article
Open access
PDF file
GHGjylije Hoti
Gjylije Hoti
Fabrizio CalderaFabrizio Caldera
Fabrizio Caldera
Claudio CeconeClaudio Cecone
Claudio Cecone
APAlberto Rubin Pedrazzo
Alberto Rubin Pedrazzo
Anastasia AnceschiAnastasia Anceschi
Anastasia Anceschi
Francesco TrottaFrancesco Trotta
Francesco Trotta
The cross-linking density influences the physicochemical properties of cyclodextrin-based nanosponges (CD-NSs). Although the effect of the cross-linker type and content on the NSs performance has been investigated, a detailed study of the cross-linking density has never been performed. In this contribution, nine ester-bridged NSs based on β-cyclodextrin (β-CD) and different quantities of pyromellitic dianhydride (PMDA), used as a cross-linking agent in stoichiometric proportions of 2, 3, 4, 5, 6, 7, 8, 9, and 10 moles of PMDA for each mole of CD, were synthesized and characterized in terms of swelling and rheological properties. The results, from the swelling experiments, exploiting Flory–Rehner theory, and rheology, strongly showed a cross-linker content-dependent behavior. The study of cross-linking density allowed to shed light on the efficiency of the synthesis reaction methods. Overall, our study demonstrates that by varying the amount of cross-linking agent, the cross-linked structure of the NSs matrix can be controlled effectively. As PMDA βCD-NSs have emerged over the years as a highly versatile class of materials with potential applications in various fields, this study represents the first step towards a full understanding of the correlation between their structure and properties, which is a key requirement to effectively tune their synthesis reaction in view of any specific future application or industrial scale-up.

1 October 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Fabrizio CalderaFabrizio Caldera
Fabrizio Caldera
MTMaria Tannous
Maria Tannous
RCRoberta Cavalli
Roberta Cavalli
MZMarco Zanetti
Marco Zanetti
FTFrancesco Trotta
Francesco Trotta

14 May 2020 in Polymers
Verified
Journal Article
Open access
PDF file
IKIlona Krabicová
Ilona Krabicová
SASilvia Lucia Appleton
Silvia Lucia Appleton
MTMaria Tannous
Maria Tannous
GHGjylije Hoti
Gjylije Hoti
Fabrizio CalderaFabrizio Caldera
Fabrizio Caldera
Francesco TrottaFrancesco Trotta
Francesco Trotta
Nowadays, research in the field of nanotechnology and nanomedicine has become increasingly predominant, focusing on the manipulation and development of materials on a nanometer scale. Polysaccharides have often been used as they are safe, non-toxic, hydrophilic, biodegradable and are low cost. Among them, starch derivatives and, in particular, cyclodextrin-based nanosponges (CD NSs) have recently emerged due to the outstanding properties attributable to their peculiar structure. In fact, alongside the common polysaccharide features, such as the presence of tunable functional groups and their ability to interact with biological tissues, thus giving rise to bioadhesion, which is particularly useful in drug delivery, what makes CD NSs unique is their three-dimensional network made up of crosslinked cyclodextrin units. The name “nanosponge” appeared for the first time in the 1990s due to their nanoporous, sponge-like structure and responded to the need to overcome the limitations of native cyclodextrins (CDs), particularly their water solubility and inability to encapsulate charged and large molecules efficiently. Since CD NSs were introduced, efforts have been made over the years to understand their mechanism of action and their capability to host molecules with low or high molecular weight, charged, hydrophobic or hydrophilic by changing the type of cyclodextrin, crosslinker and degree of crosslinking used. They enabled great advances to be made in various fields such as agroscience, pharmaceutical, biomedical and biotechnological sectors, and NS research is far from reaching its conclusion. This review gives an overview of CD NS research, focusing on the origin and key points of the historical development in the last 50 years, progressing from relatively simple crosslinked networks in the 1960s to today’s multifunctional polymers. The approach adopted in writing the present study consisted in exploring the historical evolution of NSs in order to understand their role today, and imagine their future.

22 March 2014 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
Francesco TrottaFrancesco Trotta
Francesco Trotta
CDChiara Dianzani
Chiara Dianzani
Fabrizio CalderaFabrizio Caldera
Fabrizio Caldera
BMBarbara Mognetti
Barbara Mognetti
RCRoberta Cavalli
Roberta Cavalli
The design of new nanocarriers as a strategy for the delivery of anti-cancer drugs offers a potential platform to overcome some limitations of current clinical treatments and to achieve targeted release into tumour tissues. Cyclodextrin-based nanosponges are a novel nanosized delivery system composed of hyper-cross-linked cyclodextrins connected in a three-dimensional network. They form porous nanoparticles with sizes lower than 500 nm, spherical shape and negative surface charge. They show a good capacity for incorporating small molecules, macromolecules, ions and gases within their structure. This review will describe some applications of cyclodextrin-based nanosponges as carriers for anticancer drugs. Recent smart nanosponges, able to be responsive to an external stimulus, will be also discussed. In vitro and in vivo experimental results, obtained with currently used molecules, such as paclitaxel, doxorubicin, 5-fluorourcil and tamoxifen, will be shown. Cyclodextrin-based nanosponges can be considered a challenging technology for the development of innovative formulations, suitable for various administration routes for anti-cancer drugs.

1 May 2015 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
PSPravin K. Shende
Pravin K. Shende
YKYogesh A. Kulkarni
Yogesh A. Kulkarni
RGR.S. Gaud
R.S. Gaud
KDKiran Deshmukh
Kiran Deshmukh
RCRoberta Cavalli
Roberta Cavalli
Fabrizio CalderaFabrizio Caldera
Fabrizio Caldera

20 October 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Nilesh Kumar DhakarNilesh Kumar Dhakar
Nilesh Kumar Dhakar
Adrián MatencioAdrián Matencio
Adrián Matencio
Fabrizio CalderaFabrizio Caldera
Fabrizio Caldera
Monica ArgenzianoMonica Argenziano
Monica Argenziano
RCRoberta Cavalli
Roberta Cavalli
Francesco TrottaFrancesco Trotta
Francesco Trotta
Resveratrol and oxyresveratrol are natural polyphenolic stilbenes with several important pharmacological activities. However, low solubility and aqueous instability are the major limitations in their drug delivery applications. In the present work, we demonstrated the encapsulation of resveratrol and oxyresveratrol with nanosponge to improve solubility and stability. Several characterization techniques were used to confirm the encapsulation of both drug molecules within the nanosponges. The high encapsulation efficiency of resveratrol (77.73%) and oxyresveratrol (80.33%) was achieved within the nanosponges. Transmission electron microscopy suggested uniform spherical size particles of resveratrol and oxyresveratrol loaded nanosponges. Compared to free drugs, better protection against UV degradation was observed for resveratrol-loaded nanosponge (2-fold) and oxyresveratrol-loaded nanosponge (3-fold). Moreover, a higher solubilization of resveratrol- and oxyresveratrol-loaded nanosponges lead to a better antioxidant activity compared to drug molecules alone. Cytotoxicity studies against DU-145 prostate cancer cell lines further suggested improved activity of both resveratrol and oxyresveratrol-loaded nanosponges without any significant toxicity of blank nanosponges.